Navamedic ASA: Broad launch for Eroxon® in Sweden today Publisert: 06.05.2024 Navamedic ASA: Annual Report 2023 Publisert: 30.04.2024 Navamedic Q1 2024: Successful product launch and steady operational progress Publisert: 30.04.2024 Navamedic ASA: Invitation to 2024 1st quarter presentation Publisert: 23.04.2024 Navamedic ASA – Mandatory notification of trade by primary insider Publisert: 15.03.2024 Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options Publisert: 15.03.2024 FørsteForrige1617181920NesteSiste
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options Publisert: 15.03.2024